Plasminogen activator inhibitor-1 deposition in the extracellular matrix of cultured human mesangial cells
- PMID: 1632457
- PMCID: PMC1886590
Plasminogen activator inhibitor-1 deposition in the extracellular matrix of cultured human mesangial cells
Abstract
Human mesangial cells secrete tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1), the latter being secreted in large excess in vitro. We demonstrate that PAI-1 is a major component of the extracellular matrix of cultured human mesangial cells, where its deposition is dependent on cell density. By immunogold silver staining, epipolarization microscopy and dispersive X-ray spectrometry, we have shown that matrix-associated PAI-1 is synthesized by spreading human mesangial cells, as indicated by the time-dependent accumulation of PAI-1 and the inhibitory effect of cycloheximide. Furthermore, by in situ hybridization, PAI-1 mRNA was detected in cultured mesangial cells. t-PA is present inside the cells, or at the cell surface, but is never associated with the extracellular matrix. Exogenous t-PA can remove matrix-associated PAI-1 without affecting cell adhesion. A similar effect was obtained by addition of urokinase-type plasminogen activator (u-PA) but not with fibrinolysis unrelated enzymes. In conclusion, PAI-1 is synthesized by human cultured mesangial cells and is deposited in the extracellular matrix by nonconfluent cells, whereas less PAI-1 is seen between confluent cells. This can explain the absence of detectable PAI-1 in normal human kidney biopsies. t-PA released by mesangial cells can bind and detach matrix PAI-1.
Similar articles
-
Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.Lab Invest. 1994 Dec;71(6):828-37. Lab Invest. 1994. PMID: 7807964
-
Cultured human mesangial cells produce both type 1 and type 2 plasminogen activator inhibitors.Thromb Haemost. 1995 Dec;74(6):1516-20. Thromb Haemost. 1995. PMID: 8772230
-
Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells.Thromb Haemost. 1990 Nov 30;64(3):412-9. Thromb Haemost. 1990. PMID: 2128971
-
Interactions between type 1 plasminogen activator inhibitor, extracellular matrix and vitronectin.Cell Differ Dev. 1990 Dec 2;32(3):287-92. doi: 10.1016/0922-3371(90)90041-t. Cell Differ Dev. 1990. PMID: 1711915 Review.
-
Modulation of the malignant phenotype with the urokinase-type plasminogen activator and the type I plasminogen activator inhibitor.Cell Differ Dev. 1990 Dec 2;32(3):277-85. doi: 10.1016/0922-3371(90)90040-4. Cell Differ Dev. 1990. PMID: 2129155 Review.
Cited by
-
PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity.Sci Rep. 2022 Jul 16;12(1):12186. doi: 10.1038/s41598-022-16518-3. Sci Rep. 2022. PMID: 35842542 Free PMC article.
-
Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.Am J Pathol. 1994 Jan;144(1):70-81. Am J Pathol. 1994. PMID: 8291613 Free PMC article.
-
Activities, localizations, and roles of serine proteases and their inhibitors in human brain tumor progression.J Neurooncol. 1994;22(2):139-51. doi: 10.1007/BF01052889. J Neurooncol. 1994. PMID: 7745466 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous